1. Home
  2. KRRO vs GDEV Comparison

KRRO vs GDEV Comparison

Compare KRRO & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

SELL

Current Price

$12.67

Market Cap

196.4M

Sector

Health Care

ML Signal

SELL

Logo GDEV Inc.

GDEV

GDEV Inc.

HOLD

Current Price

$9.09

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
GDEV
Founded
2014
2009
Country
United States
Cyprus
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
197.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRRO
GDEV
Price
$12.67
$9.09
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $21.50
N/A
AVG Volume (30 Days)
★ 212.2K
2.7K
Earning Date
11-05-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $6,392,000.00
N/A
Revenue This Year
N/A
$7.58
Revenue Next Year
N/A
$6.90
P/E Ratio
★ N/A
$5.19
Revenue Growth
★ 181.46
N/A
52 Week Low
$5.20
$8.18
52 Week High
$17.35
$25.03

Technical Indicators

Market Signals
Indicator
KRRO
GDEV
Relative Strength Index (RSI) 48.28 44.84
Support Level $11.81 N/A
Resistance Level $14.47 $12.08
Average True Range (ATR) 1.45 0.49
MACD -0.22 -0.04
Stochastic Oscillator 24.60 30.85

Price Performance

Historical Comparison
KRRO
GDEV

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: